http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0345248-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
filingDate 1989-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1991-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0345248-A3
titleOfInvention Use of the enzyme-cofactor nadph in the preparation of a pharmaceutical, pharmaceutical and preparation thereof
abstract Use of the enzyme cofactor NADPH or a salt thereofnto make one for the treatment of Parkinson's syndromensuitable drug.
priorityDate 1988-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0234733-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4579870-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394609

Total number of triples: 20.